rabbit anti-apc2 Search Results


93
Cell Signaling Technology Inc rabbit anti apc2
Rabbit Anti Apc2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/APC2+Antibody/bio_rxiv__2025__07__01__662622-160-49-51
Average 93 stars, based on 1 article reviews
rabbit anti apc2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Proteintech slc25a23
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Slc25a23, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/SLC25A23+Antibody/pmc09569204-195-51-55
Average 93 stars, based on 1 article reviews
slc25a23 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
BioGenes GmbH rabbit polyclonal anti-apc2
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Rabbit Polyclonal Anti Apc2, supplied by BioGenes GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/rabbit+anti+drr1/pm38678563-420-41-40
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-apc2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Proteintech rabbit anti apc2
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Rabbit Anti Apc2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/APC2+Antibody/pmc09747930-403-46-48
Average 93 stars, based on 1 article reviews
rabbit anti apc2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

86
Bethyl uk 12231s cdc25b antibody neb uk 9525s apc2 antibody neb uk 12301s purified anti aurkc mouse monoclonal antibody
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Uk 12231s Cdc25b Antibody Neb Uk 9525s Apc2 Antibody Neb Uk 12301s Purified Anti Aurkc Mouse Monoclonal Antibody, supplied by Bethyl, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/CD68+Recombinant+Mouse+Monoclonal+Antibody/pmc05457479__mmc2-250-22-41
Average 86 stars, based on 1 article reviews
uk 12231s cdc25b antibody neb uk 9525s apc2 antibody neb uk 12301s purified anti aurkc mouse monoclonal antibody - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

97
Santa Cruz Biotechnology rabbit anti apc2
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Rabbit Anti Apc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/%CE%B1+Tubulin+Antibody/pmc04600715-157-19-31
Average 97 stars, based on 1 article reviews
rabbit anti apc2 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti apc 2 antibodies
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Anti Apc 2 Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/Allophycocyanin+Antibody/pm23826121-65-8-13
Average 93 stars, based on 1 article reviews
anti apc 2 antibodies - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

99
Danaher Inc anti rabbit polyclonal recognizing apc2 (abcam; diluted 1:200)
(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of <t>SLC25A23</t> in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.
Anti Rabbit Polyclonal Recognizing Apc2 (Abcam; Diluted 1:200), supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti-apc2/Rabbit+Polyclonal+Anti-JAK2+(phospho+Y1007)+antibody/pmc03048047-423-14-19
Average 99 stars, based on 1 article reviews
anti rabbit polyclonal recognizing apc2 (abcam; diluted 1:200) - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

N/A
Rabbit Polyclonal Anti SNAPC2 Antibody
  Buy from Supplier

N/A
APCL / APC2 Rabbit anti-Human Polyclonal (Internal) (Unconjugated) Antibody, (50 µg)
  Buy from Supplier

N/A
This is a rabbit polyclonal antibody against SNAPC2. It was validated on Western Blot using a cell lysate as a positive control. Aviva Systems Biology strives to provide antibodies covering each member of a whole
  Buy from Supplier

N/A
SNAPC2 Antibody raised in Rabbit validated in E, WB, IHC in Human.
  Buy from Supplier

Image Search Results


(a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of SLC25A23 in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.

Journal: BioMed Research International

Article Title: Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer

doi: 10.1155/2022/4009354

Figure Lengend Snippet: (a) The mRNA expression of SLC25A7 in gastric cancer specimens was increased; N = 23 per group ( P = 0.023). (b) The mRNA expression SLC25A7 in colon cancer specimens was increased without statistical significance; N = 8 per group (ns). (c)The mRNA expression of SLC25A4 in gastric cancer specimens was decreased; N = 23 per group ( P < 0.001). (d) The mRNA expression of SLC25A23 in colon cancer specimens was decreased; N = 29 per group ( P < 0.001). (e) The protein expression of SLC25A7 in gastric cancer specimens was increased; N = 18 per group ( P = 0.043). (f) The protein expression of SLC25A7 in colon cancer specimens was increased; N = 19 per group ( P < 0.001). (g) The protein expression of SLC25A4 in gastric cancer specimens was decreased; N = 21 per group ( P < 0.001). (h) The protein expression of SLC25A23 in COAD was decreased that did not reach the statistical significance; N = 14 per group (ns). (i) Representative immunostaining picture of SLC25A7 expression in gastric normal specimens. (j) Representative immunostaining picture of SLC25A7 expression in gastric cancer specimens. (k) Representative immunostaining picture of SLC25A7 expression in colon normal specimens. (l) Representative immunostaining picture of SLC25A7 expression in colon cancer specimens. (m) Representative immunostaining picture of SLC25A4 expression in gastric normal specimens. (n) Representative immunostaining picture of SLC25A4 expression in gastric cancer specimens. (o) Representative immunostaining picture of SLC25A23 expression in colon normal specimens. (p) Representative immunostaining picture of SLC25A23 expression in colon cancer specimens.

Article Snippet: Gastric cancer and colon cancer tissues were fixed in 4% paraformaldehyde, subsequently embedded in paraffin, and sectioned at 4 μ m. The expressions of SLC25A4 (rabbit anti-SLC25A4, 861244, Zenbio, Inc., Chengdu, China) in gastric cancer, UCP1 (rabbit anti-UCP1, 23673-1-AP, Proteintech Group, Inc., Wuhan, China) in gastric cancer and colon cancer, and SLC25A23 (rabbit anti-SLC25A23, 20168-1-AP, Proteintech Group, Inc., Wuhan, China) in colon cancer were analyzed by immunohistochemistry as per the manufacturer's instructions.

Techniques: Expressing, Immunostaining